Matches in SemOpenAlex for { <https://semopenalex.org/work/W4316661749> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- W4316661749 abstract "BACKGROUND: Telogen effluvium and androgenetic alopecia (AGA) represent the most common non scarring hair diseases. In addition to medical treatments such as finasteride and minoxidil, recommendations for telogen effluvium or AGA include oral supplementation, that can be prescribed in association or before starting medical therapies. The objective of our study was to evaluate the tolerability, efficacy and the compliance of the patient of a treatment with oral supplementation in patients affected by telogen effluvium eventually associated with grade I/II of AGA according to the Ludwig Scale.METHODS: We enrolled a total of 20 female patients affected by telogen effluvium, in 7 cases associated with grade I/II of AGA according to the Ludwig scale. Patients were asked to take a supplement containing sulfurated aminoacids (L-cystine, L-methionine, liposomal glutathione) and trace elements (zinc, copper, iron, selenium) with ubidecarenone and vitamin B5. All patients underwent the dermatological examination, photography and trichoscopy, at the first visit, after 3 months and after 6 months.RESULTS: At the end of the study, clinical healing was assessed in 14 patients while 6 patients showed good improvement. 4 patients rated moderate satisfaction; 16 patients were very satisfied of the results. Trichoscopy showed important improvement in 17 patients and only 3 patients showed a moderate improvement in the hair density and diameter. All patients tolerated very well the treatment, and none of patients needed to discontinue the assumption of the tablets.CONCLUSIONS: The results of our study demonstrate the ability of a new tablet supplement with sulfurate amino acids and trace elements ingredients to effectively and safely improve the hair growth and hair loss in patients with telogen effluvium associated with mild to moderate AGA. The supplement was found to be excellently tolerated from all the patients, safe, and easily incorporated into daily routines." @default.
- W4316661749 created "2023-01-17" @default.
- W4316661749 creator A5003888665 @default.
- W4316661749 creator A5027939822 @default.
- W4316661749 creator A5064089672 @default.
- W4316661749 creator A5086866758 @default.
- W4316661749 creator A5089375278 @default.
- W4316661749 date "2023-03-01" @default.
- W4316661749 modified "2023-10-16" @default.
- W4316661749 title "Oral supplementation in female telogen effluvium: a clinical and instrumental objective evidence of efficacy and tolerability of new oral cosmetic treatment" @default.
- W4316661749 cites W1978879499 @default.
- W4316661749 cites W1979250576 @default.
- W4316661749 cites W2081708811 @default.
- W4316661749 cites W2771059226 @default.
- W4316661749 cites W2890046521 @default.
- W4316661749 cites W2969862999 @default.
- W4316661749 cites W3020837623 @default.
- W4316661749 cites W3194883944 @default.
- W4316661749 cites W3203351742 @default.
- W4316661749 doi "https://doi.org/10.23736/s2784-8671.22.07416-3" @default.
- W4316661749 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36645365" @default.
- W4316661749 hasPublicationYear "2023" @default.
- W4316661749 type Work @default.
- W4316661749 citedByCount "0" @default.
- W4316661749 crossrefType "journal-article" @default.
- W4316661749 hasAuthorship W4316661749A5003888665 @default.
- W4316661749 hasAuthorship W4316661749A5027939822 @default.
- W4316661749 hasAuthorship W4316661749A5064089672 @default.
- W4316661749 hasAuthorship W4316661749A5086866758 @default.
- W4316661749 hasAuthorship W4316661749A5089375278 @default.
- W4316661749 hasConcept C126322002 @default.
- W4316661749 hasConcept C16005928 @default.
- W4316661749 hasConcept C197934379 @default.
- W4316661749 hasConcept C2776360568 @default.
- W4316661749 hasConcept C2778375690 @default.
- W4316661749 hasConcept C71924100 @default.
- W4316661749 hasConceptScore W4316661749C126322002 @default.
- W4316661749 hasConceptScore W4316661749C16005928 @default.
- W4316661749 hasConceptScore W4316661749C197934379 @default.
- W4316661749 hasConceptScore W4316661749C2776360568 @default.
- W4316661749 hasConceptScore W4316661749C2778375690 @default.
- W4316661749 hasConceptScore W4316661749C71924100 @default.
- W4316661749 hasIssue "1" @default.
- W4316661749 hasLocation W43166617491 @default.
- W4316661749 hasLocation W43166617492 @default.
- W4316661749 hasOpenAccess W4316661749 @default.
- W4316661749 hasPrimaryLocation W43166617491 @default.
- W4316661749 hasRelatedWork W1947943177 @default.
- W4316661749 hasRelatedWork W2081730626 @default.
- W4316661749 hasRelatedWork W2087016115 @default.
- W4316661749 hasRelatedWork W2287714632 @default.
- W4316661749 hasRelatedWork W2349164817 @default.
- W4316661749 hasRelatedWork W2363981502 @default.
- W4316661749 hasRelatedWork W3194061732 @default.
- W4316661749 hasRelatedWork W4291368533 @default.
- W4316661749 hasRelatedWork W4297184974 @default.
- W4316661749 hasRelatedWork W2512502926 @default.
- W4316661749 hasVolume "158" @default.
- W4316661749 isParatext "false" @default.
- W4316661749 isRetracted "false" @default.
- W4316661749 workType "article" @default.